Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Lynparza fails a PhIII test in colorectal cancer, cutting off big R&D avenue for Merck and AstraZeneca
3 years ago
R&D
Pharma
Safety scare cleared and early data in hand, Ultragenyx dishes out $75M to buy rare disease partner
3 years ago
Deals
Following Luxturna and slate of eye disease approvals, Roche adds another ophthalmology partner for AAV gene ...
3 years ago
Startups
Deals
Eisai shutters oncology unit, cuts around 80 jobs
3 years ago
Pharma
Biogen sees more than 330 departures from MA-based sites since last summer
3 years ago
Pharma
GSK nets a deal with Canadian government for flu vaccine manufacturing
3 years ago
Pharma
Manufacturing
Khloé Kardashian strikes again with migraine med Nurtec marketing in ‘all in one’ push
3 years ago
Pharma
Marketing
MilliporeSigma uses DOD funds to expand Wisconsin-based manufacturing site
3 years ago
Manufacturing
Pharma R&D spending in the US more than doubles in a decade, PhRMA survey finds
3 years ago
Pharma
Europe buys 54,000 more doses of Bavarian Nordic's monkeypox vaccine as cases increase
3 years ago
Pharma
Amgen expands StoryCorps oncology campaign with celebrity actor, preps for upcoming health equity stories
3 years ago
Pharma
Marketing
GSK's consumer health unit Haleon off to a rough start
3 years ago
Pharma
BlackRock joins Andrew Lo's risk analysis firm to search for odds-on biotech bets in turbulent times
3 years ago
Deals
Bioregnum
Editas hires top Sanofi scientist for CMO as C-suite shuffle continues
3 years ago
R&D
Immunocore is the latest to nab a private placement, securing $140M to pursue more TCR R&D
3 years ago
Financing
An old epilepsy med gets oral liquid formulation nod; PMV pairs up ASCO standout with Keytruda
3 years ago
News Briefing
Weeks after rare disease drug got spurned, Acer returns to FDA for second shot
3 years ago
FDA+
Sesen Bio pauses bladder cancer drug work, offloads eye disease antibodies to Roche
3 years ago
R&D
Eliem delays a depression trial, indefinitely postpones another after blaming CMC issues for low drug exposure
3 years ago
R&D
Sanofi waves the white flag on Regulus' microRNA program targeting rare kidney disease
3 years ago
Pharma
Samsung’s CDMO arm commits to $324M land purchase for a second bio campus
3 years ago
Financing
Manufacturing
Oxford Science Enterprises collects $300M to offer spinouts 'scale-up capital'
3 years ago
Financing
DNA sequencing giant Illumina battles antitrust regulators and growing competition
3 years ago
Pharma
In Focus
Nestlé puts down $40M, kicks off deal with gut microbiome specialist to fight food allergies
3 years ago
Deals
First page
Previous page
491
492
493
494
495
496
497
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit